Page last updated: 2024-09-05

olpadronic acid and Conus Medullaris Syndrome

olpadronic acid has been researched along with Conus Medullaris Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arndt, JW; Hamdy, NA; Lycklama à Nijeholt, GA; Papapoulos, SE; Pelger, RC; Soerdjbalie-Maikoe, V; Zwinderman, AH	1

Other Studies

1 other study(ies) available for olpadronic acid and Conus Medullaris Syndrome

Article	Year
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:4 Topics: Aged; Combined Modality Therapy; Diphosphonates; Humans; Lumbar Vertebrae; Male; Pain; Palliative Care; Prostatic Neoplasms; Retrospective Studies; Spinal Cord Compression; Spinal Neoplasms; Strontium; Thoracic Vertebrae; Treatment Outcome	2002

Article

Year

Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton.

European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:4

Topics: Aged; Combined Modality Therapy; Diphosphonates; Humans; Lumbar Vertebrae; Male; Pain; Palliative Care; Prostatic Neoplasms; Retrospective Studies; Spinal Cord Compression; Spinal Neoplasms; Strontium; Thoracic Vertebrae; Treatment Outcome

2002